PNS131 DO THE EVOLVING MARKET ACCESS POLICY DYNAMICS AND INCREASING IMPORTANCE OF CLINICAL AND HEALTH ECONOMIC EVIDENCE REPRESENT THE NEXT BIG OPPORTUNITY FOR PHARMA TO DEMONSTRATE VALUE IN CHINA?
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.2032
https://www.valueinhealthjournal.com/article/S1098-3015(19)34410-9/fulltext
Section Title :
Section Order :
11766
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34410-9&doi=10.1016/j.jval.2019.09.2032